Show simple item record

dc.contributor.authorChivers Seymour, K
dc.contributor.authorPickering, R
dc.contributor.authorRochester, L
dc.contributor.authorRoberts, H
dc.contributor.authorBallinger, C
dc.contributor.authorHulbert, S
dc.contributor.authorKunkel, D
dc.contributor.authorMarian, I
dc.contributor.authorFitton, C
dc.contributor.authorMcIntosh, E
dc.contributor.authorGoodwin, V
dc.contributor.authorNieuwboer, A
dc.contributor.authorLamb, S
dc.contributor.authorAshburn, A
dc.date.accessioned2019-02-12T11:38:43Z
dc.date.issued2019-04-03
dc.description.abstractObjective: To estimate the effect of a physiotherapist-delivered fall-prevention programme for people with Parkinson’s (PwP). Methods: People at risk of falls with confirmed Parkinson’s were recruited to this multi-centre, pragmatic, investigator blind, individually randomised controlled trial with pre-specified sub-group analyses. 474 PwP (Hoehn and Yahr 1-4) were randomised: 238 allocated to a physiotherapy programme and 236 to control. All participants had routine care; the control group received a DVD about Parkinson’s and single advice session at trial completion. The intervention group (PDSAFE) had an individually tailored, progressive home-based fall-avoidance strategy training programme with balance and strengthening exercises. The primary outcome was risk of repeat-falling, collected by self-report monthly diaries, 0 to 6 months post-randomisation. Secondary outcomes included, Mini-BESTest for balance, chair stand test, Falls Efficacy, freezing of gait, health related quality of life (Euroqol EQ-5D), Geriatric Depression Scale, Physical Activity Scale for the Elderly and Parkinson’s disease Questionnaire, fractures and rate of near-falling. Results: Average age, 72 years and 266 (56%) were men. By 6 months 116 (55%) of the control group, and 125 (61.5%) of the intervention group reported repeat falls (controlled odds ratio 1.21, 95% confidence interval 0.74 to 1.98, P=0.447). Secondary sub-group analyses suggested a different response to the intervention between moderate and severe disease severity groups. Balance, falls efficacy and chair stand time improved with near-falls reduced in the intervention arm. Conclusion: PDSAFE did not reduce falling in this pragmatic trial of PwP. Other functional tasks improved and reduced fall rates were apparent among those with moderate disease.en_GB
dc.description.sponsorshipDepartment of Healthen_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationPublished online 3 April 2019.en_GB
dc.identifier.doi10.1136/jnnp-2018-319448
dc.identifier.grantnumber10/57/21.en_GB
dc.identifier.urihttp://hdl.handle.net/10871/35914
dc.language.isoenen_GB
dc.publisherBMJ Publishing Groupen_GB
dc.rights© Authors 2019. Reuse of this manuscript version (excluding any databases, tables, diagrams, photographs and other images or illustrative material included where a another copyright owner is identified) is permitted strictly pursuant to the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC-BY-NC 4.0). https://creativecommons.org/licenses/by-nc/4.0/. No commercial re-use. See rights and permissions. Published by BMJ.en_GB
dc.titleA multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson’sen_GB
dc.typeArticleen_GB
dc.date.available2019-02-12T11:38:43Z
dc.identifier.issn0022-3050
dc.descriptionThis is the author accepted manuscript. The final version is available from BMJ Publishing Group via the DOI in this record.en_GB
dc.identifier.journalJournal of Neurology, Neurosurgery and Psychiatryen_GB
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2019-02-11
exeter.funder::Department of Healthen_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-02-11
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-02-12T10:13:56Z
refterms.versionFCDAM
refterms.dateFOA2019-04-04T12:11:38Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Authors 2019. Reuse of this manuscript version (excluding any databases, tables, diagrams, photographs and other images or illustrative material included where a another copyright owner is identified) is permitted strictly pursuant to the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC-BY-NC 4.0). https://creativecommons.org/licenses/by-nc/4.0/. No commercial re-use. See rights and permissions. Published by BMJ.
Except where otherwise noted, this item's licence is described as © Authors 2019. Reuse of this manuscript version (excluding any databases, tables, diagrams, photographs and other images or illustrative material included where a another copyright owner is identified) is permitted strictly pursuant to the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC-BY-NC 4.0). https://creativecommons.org/licenses/by-nc/4.0/. No commercial re-use. See rights and permissions. Published by BMJ.